# Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women

> **NCT00883272** · — · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 32 (actual)

## Conditions studied

- Menopause
- Thrombophilia

## Interventions

- **DIETARY_SUPPLEMENT:** DT56a (Femarelle) [Se-cure pharmaceuticals, Dalton, Israel]

## Key facts

- **NCT ID:** NCT00883272
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883272, "Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00883272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*